Solution and Answer Guide STERILE COMPOUNDING 1ST EDITION JAHANGIR MOINI, OBEHI ENABULELE, ANTHONY SCOTT

Solution and Answer Guide
STERILE COMPOUNDING 1ST EDITION JAHANGIR MOINI, OBEHI ENABULELE, ANTHONY
SCOTT
CHAPTER 1: INTRODUCTION
TABLE OF CONTENTS
Answer Key with Rationales for End-of-Chapter Questions ..................................... 1
Multiple Choice ............................................................................................................ 1
Fill in the Blank............................................................................................................. 4
ANSWER KEY WITH RATIONALES FOR END-OF-CHAPTER QUESTIONS
MULTIPLE CHOICE
1. Which of the following organizations published Principles of Sterile Product
Preparation in 1995?
a. ISMP
b. NIH
c. ASHP
d. FDA
Answer: C
Solution: This publication is a textbook of fundamentals for pharmacists,
pharmacy technicians, and students. It offers an understanding of the new,
stricter sterile compounding guidelines and supplements other educational
materials published by the ASHP.
2. To perform sterile compounding, the pharmacy technician must have how many
hours of continuing education?
a. 2
b. 5
c. 10
d. 15
Answer: B
Solution: To perform sterile compounding, the pharmacy technician must have 5
hours of sterile compounding continuing education every year. These hours
count toward the 20 continuing education hours for CPhT recertification. 

3. Which of the following sections of the USP involves sterile compounding?
a. USP 600
b. USP 795
c. USP 797
d. USP 800
Answer: C
Solution: The USP 797 involves sterile compounding. It covers compounding of
hazardous and nonhazardous drugs, with a focus on protection of sterile
compounds and environments from contamination.
4. In ambulatory care compounding, trained pharmacy technicians must follow all of
the following associations’ guidelines, except:
a. USP
b. CDC
c. FDA
d. State board of pharmacy
Answer: B
Solution: In ambulatory care compounding, trained pharmacy technicians must
follow USP, FDA, and state board of pharmacy guidelines, but not CDC
guidelines. The USP and FDA make up the federal regulators for ambulatory
care compounding.
5. Which of the following radionuclides is used for the treatment of metastatic bone
cancer?
a. Strontium
b. Chromium
c. Xenon
d. Iodine-131